Our mission

We believe know that CLINICALLY VALUABLE INFORMATION FROM TUMOR GENOME IS WAITING TO BE DISCOVERED

By combining cutting-edge genome analysis with latest technological breakthroughs in AI we develop analytical tools delivering key answers to patients and clinicians.

Meet our team!

Our interdisciplinary team combines expertise in DNA chemistry and cell biology, with AI and machine learning to provide cutting-edge genome analysis and develop new approaches to personalized medicine. We work together toward a common vision. This interdisciplinary environment allows us to achieve the impossible.

Leadership

Paweł Zawadzki

CEO

After obtaining a triple PhD (chemistry, physics, biology) in 2009, Pawel spent 7 years at Oxford University studying DNA technology at Departments of Physics, Biochemistry and Oncology. In 2017 he established DNA repair focused research group at Adam Mickiewicz University. 2018, the MNM Diagnostics was born as a need to bring genomics directly to patient's bed by merging genomics with AI technologies.

Katarzyna Zawadzka

COO

A graduate of Biotechnology at Adam Mickiewicz University in Poznań. A long-time employee of the DNA Sequencing Laboratory. She continued her scientific career at the University of Oxford, where she gained knowledge, experience and scientific independence.
After returning to Poland in 2017, together with a group of enthusiastic specialists/scientists, she founded the company MNM Diagnostics, where she conducts research and analyses on personalized diagnostics and the selection of anti-cancer targeted therapies.

Paweł Sztromwasser

Head of Technology Development

Obtained his Ph.D. in 2014 at the University of Bergen, Norway. His thesis focused on sensitivity analysis of high-throughput bioinformatics workflows. During the PhD at the Computational Biology Unit, and afterwards as a postdoc fellow at the Center for Medical Genetics (MGM) at the Haukeland University Hospital in Bergen, Pawel gained broad experience in deep sequencing (NGS) data analysis, high performance and cloud computing, software engineering, and human genetics. He had an opportunity to play a pivotal role in establishing a clinical whole-exome sequencing facility at the hospital, and after returning to Poland, in building a microbial sequencing facility at the National Veterinary Research Institute in Puławy, Poland. After acquiring a prestigious MSCA funded fellowship, and successful completion of the project at the Medical University of Lodz, Pawel joined MNM to pursue the ambisius mission of introducing whole-genome sequencing into routine patient diagnostics. His current main role is leading a team of programmers, bioinformaticians, and data-scientists that work side by side with geneticists and clinical scientists to develop cutting edge diagnostic tools in cancer, and to enable whole genome sequencing at a population scale.

Alicja Woźna

Head of R&D

A graduate of English Biotechnology at the Faculty of Biology, Adam Mickiewicz University in Poznań. In 2017, she started a modern interdisciplinary doctoral programm, combining the knowledge of molecualar biology, genomics and physics at the Faculty of Physics, AMU. During many internships in pioneering Polish and foreign institutions, e.g. École Normale Supérieure de Lyon, she gained expertise in applying sequencing methods to cancer research. Currently, she actively participates in the development of MNM Diagnostics as a Technology Development Manager, where she co-creates comprehensive AI-powered diagnostic tools for any type of cancer therapy. Alicja is passionate about sports and criminal literature.

Katarzyna Ferdyn

Head of Polish Biobanking Center

Advisor to the Management Board at Polish Stem Cells Bank, Director of the Polish BioBanking Center, established by MNM Diagnostics. In 2004, she entered the biotechnology industry. She has extensive experience in modeling, mapping, implementing and managing processes in tissue and cell biobanks, Pharma companies, diagnostic laboratories, etc. She designed and implemented QMS (Quality Management System) for several Institutions. The results of her work have been appreciated by governmental as well as commercial institutions. The quality of her accomplishments was confirmed by the award from the Minister of Health in the scope of conducted activity for the tissue and cell banks. Since 2015, she has been cooperating as a QMS Technical Expert at BBRI-ERIC. She is also a representative in the Polish Committee for Standardization (PKN) in KT 287 for Biotechnology, actively participating in the work on the ISO 20387 Biotechnology-Biobanking-General requirements for Biobanking.

Paula Dobosz

Head of Scientific Development

Geneticist, specialised in Genomic Medicine. Interested in immunooncology and cancer genomics. Her scientific journey in medicine and molecular genetics started in Jagiellonian University in Cracow, she's also alumna of the Warsaw Medical University and Warsaw Academy of Physical Education. In 2018 became one of the first people in the world to achieve Genomic Medicine specialisation in Cambirdge University MedSchool. In order to understand oncology patients, she also studied clinical psychology in Warsaw. After PhD studies, she was working, studying and conducting research in Cambridge University (UK), Tel Aviv University (IL) or Georgetown University (USA). Apart from her current position in MNM as a Chief of Scientific Development, she's involved in science popularisation and scientific PR.

Michał Górczewski

Head of Finance

A graduate of Edinburgh Napier University. He initially gained experience in international institutions such as the JP Morgan investment bank, RBS and State Street Bank and Trust. After returning to Poland, he worked in the investment industry, both in asset management and an insurance company, where he was the head of the investment department. In addition, he also worked in the e-commerce industry, where he was responsible for all activities of the finance department. At MNM Diagnostics, he is responsible for the company’s financial activities and supports the company in developing on a new market and co-creates a strategy for further development.

Michał Kozłowski

Head of Commercial

In 2012 obtained his PhD in Chemistry at Adam Mickiewicz University in Poznań. A Graduate of Executive Master of Business Administration at Poznań University of Economics and Business.
He initially gained experience in companies such as eSmoking Institute, eSmoking Liquids, CHIC and BAT. His main responsibilities included Quality Management System Implementation (ISO 9001 and 17 025), Quality Assurance, R&D, Product Safety and Compliance and Import.
A former member of Technical Committee and Working Groups of CEN (European Committee for Standardization) and PKN (Polish Committee for Standardization) in the area of alternative tobacco products.
At MNM Diagnostics, he is responsible for the creation, development and management of the Commercial part of business (including commercial strategy co-creation).
Privately a beekeeper and enthusiast of street theatre.

Scientific advisory board

Kelly Gordon, PhD

Regulatory

Walter Carney, PhD

Biomarker Validation

Frances Toneguzzo, PhD

IP Strategy

Career

Want to join us?  See current job offers!

Masz pytania lub wątpliwości?

Napisz do nas

    Wyrażam zgodę na newsletter

    Zapoznałem się i akceptuję politykę prywatności oraz klauzulę informacyjną
    polityka prywatności | klauzula informacyjna

    W pośpiechu?

    Pobierz ulotkę



      jestem pacjentemjestem lekarzemjestem studentem
      Wyrażam zgodę na newsletter
      Zapoznałem się i akceptuję politykę prywatności oraz klauzulę informacyjną
      polityka prywatności
      klauzula informacyjna